Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01384240 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of a Low-Cost High Resolution Microendoscope for the Detection of Lower Gastrointestinal Neoplasia
A Early Phase 1 study, sponsored by Anandasabapathy, Sharmila, M.D..
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 183
- Enrollment target
NCT01384240: Clinical Trial Early Phase 1 study, sponsored by Anandasabapathy, Sharmila, M.D..
NCT01384240 is a Early Phase 1 study that was terminated before completion, run by Anandasabapathy, Sharmila, M.D.. The registered enrollment target is 183 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (245% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01384240, a Early Phase 1 study, was terminated before completion, sponsored by Anandasabapathy, Sharmila, M.D..
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 183 participants
- Enrollment target
Study Summary
The overall objective of this study is to obtain data to evaluate whether high-resolution imaging of the colon can assist clinicians in detecting dysplastic (precancerous) and neoplastic areas. This is a pilot study of a novel technology, a miniaturized microscope device which can be used during standard endoscopy to image the gastrointestinal epithelium. Theoretically, by visualizing superficial mucosal changes at a high-resolution and magnification, the investigators will be able to obtain optical images that can be used to guide endoscopic biopsy and polypectomy. This may foster the selective targeting of dysplasia/neoplasia, thereby improving diagnostic accuracy.
Interventions
- DRUG Proflavine Hemisulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2010-04 |
| Est. Completion | 2014-05 |
| Phase | Early Phase 1 |
Why NCT01384240 stopped before completion
NCT01384240 is an interventional study that assigns participants to a tested intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (245% higher).
The record links to 0 conditions, and to 1 intervention - of which Proflavine Hemisulfate is the first listed.
NCT01384240 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01384240 about?
NCT01384240 is a clinical study titled "Evaluation of a Low-Cost High Resolution Microendoscope for the Detection of Lower Gastrointestinal Neoplasia". The overall objective of this study is to obtain data to evaluate whether high-resolution imaging of the colon can assist clinicians in detecting dysplastic (precancerous) and neoplastic areas. This is a pilot study of a novel technology, a miniaturized microscope device which can be used during sta...
What is the current status of trial NCT01384240?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 183 participants. The study started on 2010-04. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01384240?
The interventions under investigation include: Proflavine Hemisulfate (DRUG).
Who is sponsoring clinical trial NCT01384240?
This trial is sponsored by Anandasabapathy, Sharmila, M.D., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01384240's enrollment target sits among peer trials
183 75th of 2000 higher than 1,926 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03859297 · 183 participants · NA
Mechanisms of Rumination Change in Adolescent Depression
- NCT04270591 · 183 participants · Phase 1
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
- NCT06764615 · 183 participants · Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- NCT06872684 · 183 participants · NA
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia